Adults diagnosed with long COVID were more likely to develop high blood pressure than those without a long COVID diagnosis in a large Swedish study. The association appeared among people who had not been hospitalized for their initial COVID-19 infection.
Drugs meant to calm the immune system may carry a troubling downside. New research from the Norwegian University of Science and Technology suggests that a common class of anti-inflammatory medicines can make it easier for some viruses to get into…
— But study's observational design and lack of a control group limit the findings' impact WASHINGTON -- People with long COVID reported significantly better functioning and symptom improvements after taking low-dose naltrexone, according to a small retrospective cohort study. Symptom burdens declined…
Dr. Penelope Markham, BioVie’s Senior Vice President and Program Lead for Long COVID, will share results from the Company’s Phase 2 ADDRESS-LC trial evaluating bezisterim for the treatment of the... BioVie Invited to Present Data on Bezisterim in Long COVID at…
This story originally appeared on DocWire News. A study, published in Frontiers in Public Health, examined the risk factors associated with post-COVID-19 condition among patients who had previously been hospitalized with COVID-19. The study was conducted because individuals who experience…
A protein released by infected cells can help neighboring cells prepare their defenses against respiratory syncytial virus, or RSV. Adding more of that protein before infection reduced infectious virus levels roughly tenfold in laboratory experiments. The finding points toward a…
Scientists have uncovered changes inside taste buds that may help explain why some people struggle to taste food more than a year after recovering from COVID-19. The findings point to disruptions in the molecular signals responsible for detecting certain flavors,…
SAN DIEGO — Patients with severe symptoms of long COVID experienced relief with 12 weeks of Bezisterim therapy, according to a poster presented at the 151st Annual Meeting of the American Neurological Association. Bezisterim has the potential to be the first drug approved…
University of Colorado Anschutz researchers found that HSV-1, the virus that causes cold sores, can reprogram the brain’s immune cells, potentially linking viral infection to chronic inflammation and increased vulnerability to Alzheimer’s disease. A very common virus may do more…
Despite the upheaval of COVID-19, French participants reported higher well-being scores during the pandemic, while researchers found that everyday illness symptoms had a far greater association with how people felt than seasonal or demographic factors. A recent BMC Public Health…
Long COVID and post-viral fatigue: symptoms, research, treatment trials and the lives of patients.
An article joins this feed when it matches these terms. Each one is also a search of its own.